Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-04-15 Sale |
2025-04-16 5:00 pm |
Rapport Therapeutics Inc. | RAPP | Bredt David Chief Scientific Officer |
8,500 | $9.5659 | $81,310 | 460,642 (Direct) |
View |
| 2025-03-14 Sale |
2025-03-17 5:00 pm |
Rapport Therapeutics Inc. | RAPP | Bredt David Chief Scientific Officer |
8,500 | $10.85 | $92,205 | 469,142 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-03 Option Award |
2025-02-04 5:30 pm |
N/A 2035-02-03 |
Rapport Therapeutics Inc. | RAPP | Bredt David Chief Scientific Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2024-06-06 Option Award |
2024-06-10 7:43 pm |
N/A 2034-06-05 |
Rapport Therapeutics Inc. | RAPP | Bredt David Chief Scientific Officer |
28,302 | $0 | 28,302 (Direct) |
View |
Ownership |
2024-06-06 7:03 pm |
N/A N/A |
Rapport Therapeutics Inc. | RAPP | Bredt David Chief Scientific Officer |
0 | $0 | 673,624 (Direct) |
View |